Introduction
Adenosine has been shown to increase the 5 release of both histamine and 5-hydroxytryptamine (5HT) 6 from rat isolated mast cells. This occurs only after such cells have been prestimulated with, for example, an antigen 2, 3, 6 or the ionophore A23187.1,4,5 Recent evidence suggests that in antigenically stimulated mast cells in culture adenosine increases the release of amines stored in the granules via activation of adenosine type 3 (A3) receptors7 Some of the haemodynamic actions of injected adenosine in vivo also have been attributed to the release of histamine and/or 5HT from mast cells as a result of activation of A receptors8-m. The wide heterogeneity among mast cells located in 11 12 different tissues, however, prompted us to explore the extent to which an involvement of A receptors is a general phenomenon.
Various methods may be used to study mast cell degranulation. Many workers have used rat (C) Compounds tested as possible agonists were adenosine itself; inosine, which binds weakly to A1, A2 and A3 receptors;
ribofuranuronamide (IB-MECA), which is thought to act predominantly via A3 receptors; e and N6-cyclopentyladenosine (CPA), which acts primarily via A receptors.
Results
Adenosine (1 M), inosine (100 M), NECA (0.1 xM) and CPA (0.1 M) were each found to cause significant degranulation of the mast cells in milky spots of the rat isolated omentum (Fig.  l a,b) . Ten-fold lower concentrations of each of these compounds, however, failed to exert a significant degranulating effect (Fig. l a,b) . Tenfold higher concentrations of adenosine (10 txM) and of NECA (1 xM) were also without a significant degranulating effect (Fig. l a,b) , whereas a ten-fold increase in the concentration of CPA (to 1 btM) caused almost the same amount of degranulation as the lower concentration of O. 1 xM (Fig. l b) . IB-MECA was ineffective in the present experiments in a wide concentration range of O. 1 1 O0 bI,M (Fig. 1 a) .
Pre-treatment of the omentum with 8PT
(1 lxM) significantly reduced the degranulating effects of adenosine (1 IxM), inosine (100 btM) and NECA (0.1 btM) (Fig. l a,b) . Pretreatment of the omentum with DPCPX (0.01 btM) significantly reduced the responses to both NECA (0.1 xM) and CPA (0.1 IM) (Fig. l b) (Fig. l b) 18 ( Fig. l a,b) . In contrast, IB-MECA, which is a much more powerful activator of A 3 receptors than of A or A2 receptors, 6 unexpectedly showed no effect, even when tested at a concentration of 100 (Fig. l a) , suggesting that A 3 receptor stimulation was not involved. This is in marked contrast to the observation that A3 activation can cause murine mast cells to degranulate in vivo. 9 Moreover, the application of CPA, a relatively specific A1 receptor agonist, 17 caused a significant de- gree of mast cell degranulation in the present experiments (Fig. l b) . It is important to note also that pretreatment with DPCPX, a relatively specific A1 receptor antagonist, 9 significantly reduced the degranulating effects of both CPA and NECA (Fig. l b) . These results, therefore, strongly suggest that involvement of A receptors predominated in the present situation. A2 receptor activation, on the other hand, is unlikely to have been important. A raised level of cyclic AMP, which one might expect to result from any A2 receptor stimulation, does not cause a release of amines from mast cells. [2] [3] [4] This also accords with the fact that any A2-stimulating action of NECA which might have been unmasked after blocking its A receptormediated effect with DPCPX, actually produced no observable effect on degranulation in the present experiments (Fig. lb) . It is worth noting here that other workers have found that 10 adenosine was less active than 1 26 Hence, mast cell degranulation that was observed here may have been produced indirectly, rather than as a direct result of adenosine receptor stimulation of the mast cell itself. Other workers have put forward a similar proposition.
In support of this hypothesis, it was found that pretreatment of the omentum with BN52021, a PAF-receptor antagonist, 22 significantly reduced the degranulating effects of added CPA, although indomethacin, a cyclo-oxygenase inhibitor, 23 did not (Fig.   l b) . Under 
